Blocking CD30 on CD19 CAR T cells augments their functional capacities against B-cell leukemia/lymphoma
Artículo
Acceso abierto
Artículo
DOAJ
Adoptive therapy with CD19 chimeric antigen receptor (CAR) T cells is effective against B-cell malignancies; however, T-cell activation rapidly declines, increasing the risk of early leukemia relapses. To augment CD19 CA...
LCC LCC:Immunologic diseases. AllergyIdioma eng
Acceso abiertoRuta libre sin proxy. Acceso recomendado cuando no hay suscripción activa.
Open Access